Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: A brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) study

BACKGROUND: The Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) trial compared the use of eptifibatide with placebo in 2064 coronary intervention patients. It was previously reported that Canadian patients had reduced rates of 30-day and one-year...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Madan, Mina, Nikhil, Janarthan, Hellkamp, Anne S, Pieper, Karen S, Labinaz, Marino, Cohen, EA, Buller, Christopher E, Cantor, Warren J, Seidelin, Peter, Ducas, John, Carere, Ronald G, Natarajan, Madhu K, O’Shea, J Conor, Tcheng, James E
Format: Artigo
Sprache:Inglês
Veröffentlicht: Pulsus Group Inc 2009
Schlagworte:
Clinical Studies
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2732380/
https://ncbi.nlm.nih.gov/pubmed/19668787
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge